- News Home
17 April 2014 12:48 pm ,
Vol. 344 ,
Officials last week revealed that the U.S. contribution to ITER could cost $3.9 billion by 2034—roughly four times the...
An experimental hepatitis B drug that looked safe in animal trials tragically killed five of 15 patients in 1993. Now,...
Using the two high-quality genomes that exist for Neandertals and Denisovans, researchers find clues to gene activity...
A new report from the Intergovernmental Panel on Climate Change (IPCC) concludes that humanity has done little to slow...
Astronomers have discovered an Earth-sized planet in the habitable zone of a red dwarf—a star cooler than the sun—500...
Three years ago, Jennifer Francis of Rutgers University proposed that a warming Arctic was altering the behavior of the...
- 17 April 2014 12:48 pm , Vol. 344 , #6181
- About Us
Wonder Drug Wunderkind
23 March 1999 8:00 pm
would have been the 92nd birthday of Swiss-born Italian pharmacologist Daniel Bovet, whose discoveries helped give rise to the modern pharmaceutical industry. As a young researcher in the 1930s, Bovet identified sulfanilamide as the active agent in Prontosil--a dye that combated streptococcal infections--and subsequently launched the large-scale production of the first sulfa antibiotics, or "wonder drugs."
In the early 1940s, Bovet synthesized the first antihistamines used in modern medicine. And after studying the muscle-relaxant properties of curare, a poison used by certain South American Indians on their arrows, he designed synthetic versions for use in surgery. For these advances, Bovet won the 1957 Nobel Prize in physiology or medicine. In addition, Bovet believed that the key to treating mental illness lay in chemistry, and he contributed basic research in neuropharmacology. He died in 1992.
[Source: Emily McMurray, Ed., Notable Twentieth Century Scientists (Gale Research Inc., ITP, 1995).]